Synmosa Biopharma Corp Sustainability Reports
Synmosa Biopharma Corporation develops, manufactures, and markets pharmaceutical products and medical apparatus. Its specialized product areas include respiratory drugs, cardiovascular treatments, hormone replacement therapies, and sex hormones.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG001SL4W05
7 reports from 2020 to 2025